EP Patent

EP0434364A2 — Benzodiazepine analogs for treating panic syndrome and for directly inducing analgesia

Assigned to Merck and Co Inc · Expires 1991-06-26 · 35y expired

What this patent protects

Benzodiazepine analogs of the formula: <CHEM> are disclosed which are antagonists of gastrin and cholecystokinin (CCK) and have properties useful for treating panic syndrome and for directly inducing analgesia.

USPTO Abstract

Benzodiazepine analogs of the formula: <CHEM> are disclosed which are antagonists of gastrin and cholecystokinin (CCK) and have properties useful for treating panic syndrome and for directly inducing analgesia.

Drugs covered by this patent

remimazolam-besylate (REMIMAZOLAM BESYLATE)

Patent Metadata

Patent number: EP0434364A2
Jurisdiction: EP
Classification: —
Expires: 1991-06-26
Drug substance claim: No
Drug product claim: No
Assignee: Merck and Co Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.